Nektar Therapeutics (NKTR)
45.43
-3.73
(-7.59%)
USD |
NASDAQ |
Dec 17, 16:00
45.01
-0.42
(-0.92%)
After-Hours: 20:00
Nektar Therapeutics Accounts Payable (Quarterly): 15.56M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Amgen, Inc. | 2.838B |
| Amicus Therapeutics, Inc. | 19.10M |
| Eli Lilly & Co. | 4.262B |
| Rigel Pharmaceuticals, Inc. | 3.846M |
| Zevra Therapeutics, Inc. | 11.07M |